Tobacco smoke blocks airway cells from making a protein that protects against infection by the virus that causes COVID-19.
Neurosurgeon Michael Lim studies how to unleash the immune system to attack a type of brain cancer called glioblastoma.
A common ovarian cancer evades detection by convincing nearby immune cells to treat it as a developing fetus.
A Stanford pediatric infectious disease expert is highlighted in a new campaign to answer parents' questions about COVID-19 vaccines.
A new way to deliver mRNA as a COVID-19 vaccine may avoid side effects and increase customization to prevent infection.
'Resting' exhausted cancer-fighting immune cells enhances their tumor-killing activity, which may help people with blood and solid cancers.
A Stanford-led study of twins with and without food allergies has uncovered differences in the fecal bacteria of allergic and non-allergic individuals.
Stanford University researchers have developed a nanoparticle vaccine that has shown in mouse studies to effectively build coronavirus immunities.
Stanford scientists transformed tonsils into immunology labs in a dish, aiding research to develop vaccines for COVID-19, the flu and other diseases.
The Pfizer and Moderna COVID-19 vaccines are the first to use the RNA coding molecule to prompt our bodies to fight the virus. Here's how they work.
Understanding similarities between the Nipah virus and COVID-19 could provide clues for avoiding future novel virus outbreaks.
Stanford Medicine’s early development of testing for COVID-19 infection and antibodies helped guide government responses and stem local spread of the virus.
There's a voracious appetite for information on how SARS-CoV-2, the virus responsible for the COVID-19 pandemic, works. Here it is, in a single package.
How Stanford Medicine ramped up in the spring of 2020 to cope with a coming global pandemic and learned how to brace for the next wave of COVID-19 patients.
A Stanford research team is tasked with assessing the COVID-19 infection crisis inside California’s prisons and providing strategies to contain the virus.
Stanford researchers and colleagues have invented a genetic safety mechanism that can deactivate transplanted cells if they change in a problematic way.